本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Phibro Animal Health Corporation

34.56
+0.11500.33%
盤後34.560.0025+0.01%19:30 EDT
成交量:63.55萬
成交額:2,196.55萬
市值:14.01億
市盈率:14.22
高:35.11
開:34.12
低:34.12
收:34.45
52周最高:60.08
52周最低:28.25
股本:4,053.36萬
流通股本:2,086.24萬
量比:2.49
換手率:3.05%
股息:0.48
股息率:1.39%
每股收益(TTM):2.43
每股收益(LYR):2.43
淨資產收益率:29.72%
總資產收益率:8.48%
市淨率:3.63
市盈率(LYR):14.22

資料載入中...

2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors